Abstract
SOMETIMES, drugs administered to infants give rise to undesirable effects, detectable only years later. These effects have been sought with less vigor than those which can be recognized in the neonatal period. Hearing loss associated with neonatal streptomycin administration is a point in question. The available evidence suggests such an association. 1-8 The lack of proof indicates the need for audiometric follow-up of a group of infants given streptomycin sulfate in the newborn period. This paper documents the results of a study of children who as newborn infants received moderate doses of streptomycin for short periods of time. Material and Methods The subjects of this study were 200 children between 7 and 8½ years of age who were born in 1956 and 1957 at the Cincinnati General Hospital and were admitted to the Obstetrical Nurseries (2,000 gm [4 lb 7 oz] or more). In the newborn period, 98 of the
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
